United European Gastroenterology Journal

Article	Citations
	181
Table of Contents	167
UEG Week 2023 Oral Presentations	134
Medical guidelines must not be influenced by commercial interests	116
MRI Volumetric Changes in Perianal Fistulizing Crohn's Disease: Moving Toward a Novel Outcome Measure for Therapeutic Response	103
UEG's prospects for the future	95
Stunned by a stone—A curious case of belly trouble	77
Malignancy rates in Crohn's disease patients with perianal fistula: A German retrospective cohort study	68
Shedding a new light on gastric cancer screening	65
Artificial intelligence: The researcher's assistant or sheep in wolf's clothing?	58
Letter of Thanks for UEG Week 2022 Reviewers	53
Gallbladder polyps growth rate is an independent risk factor for neoplastic polyps	53
Global Inflammatory Bowel Disease: Opportunities and Challenges for a New Era	51
Eosinophilic oesophagitis in Denmark: Population‐based incidence and prevalence in a nationwide study from 2008 to 2018	45
Recent developments in the management of ascites in cirrhosis	44
Nodular Regenerative Hyperplasia: Report of 82 Patients and Systematic Review of Literature	44
Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION study	41
Comparison of two strategies for the management of postoperative recurrence in Crohn’s disease patients with one clinical risk factor: A multicentre IG‐IBD study	41
Quadruple therapies show a higher eradication rate compared to standard triple therapy for Helicobacter pylori infection within the LEGACy consortium. A multicenter observational study in Europ	40
Corticosteroid Use in Childhood‐Onset Inflammatory Bowel Disease: A Nationwide Cohort Study (2006–2022)	38
Sex‐ and Age‐Stratified Outcomes of Colonoscopy Versus Faecal Immunochemical Testing: Post‐Analysis of the COLONPREV Study	38
From Postoperative Prognosis to Preoperative Decision‐Making in IPMN	37
Upcoming Treatments in Celiac Disease: From Luminal Enzymes to Oral Immune Tolerance	36
Dietary Sugar and Sweetened Beverage Intake Increases Inflammatory Bowel Disease Risk: A Systematic Review and Meta‐Analysis	36
Correction to “Esophageal and Oropharyngeal Dysphagia: Clinical Recommendations From the United European Gastroenterology and European Society for Neurogastroenterology and Motility”	36

Role of compliance in Helicobacter pylori eradication treatment: Results of the European Registry on H. pylori management	35
The role of an integrated referral program for patients with liver disease: A network between hub and spoke centers	35
Issue Information	35
Correction to “A portrait of Endoscopic retrograde cholangiopancreatography and endoscopic ultrasound training programs in Europe: Current practices and opportunities for improvement”	32
Comorbidities, biomarkers and cause specific mortality in patients with irritable bowel syndrome: A phenome‐wide association study	32
	32
	32
The assessment and management of cirrhotic patients with encephalopathy	31
Association of circulating Z‐polymer with adverse clinical outcomes and liver fibrosis in adults with alpha‐1 antitrypsin deficiency	31
Primary malignant melanoma of the oesophagus	31
Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives	30
Modifying Our Environment to Improve Outcomes in Inflammatory Bowel Diseases?	29
T1 colorectal cancer patients' perspective on information provision and therapeutic decision‐making after local resection	29
Interferential therapy for chronic constipation in adults: The CON‐COUR randomizedcontrolled trial	29
Transcutaneous Auricular Vagal Nerve Stimulation to Treat Chronic Constipation: Another Therapeutic Failure?	28
Oral Microcapsule Chromocolonoscopy With Patent Blue V Improves Adenoma Detection Safely and Effectively	27
From Guideline to Clinical Practice: Towards an Era Without Surgical Site Infections	26
Issue Information	26
Issue Information	26
Drug Interaction With Advanced Therapies in Inflammatory Bowel Diseases: A Blind Spot to Tackle	26
What the European Reference Network Registry for Rare Liver Diseases Tells Us About Primary Biliary Cholangitis in European Practice	25
Inaccuracy and Bias in Endoscopic Size Estimation of Large Colorectal Polyps; Insights From a Prospective Cohort of 1828 En‐Bloc Resections	25
Disease clearance in ulcerative colitis: Is the ultimate therapeutic target?	25
Non‐Adherence to Standard Therapy in Autoimmune Hepatitis: Impact of Steroid Use and Over‐the‐Counter Medications	25
Irritable bowel syndrome: Factors of importance for disease‐specific quality of life	25
The Pivotal ‘P’s of inflammatory bowel disease: Prediction and Prevention	25
Quality of life after endoscopic procedures for chronic pancreatitis: A multicentre study	24
Secondary Prophylaxis of Cirrhotic Gastric Variceal Bleeding: Addition of Non‐Selective Beta‐Blockers to Endoscopic Combined Treatment	23
Issue Information	23
Homologous Repair‐Deficient Pancreatic Cancer: Refined Targeting of DNA Damage Response is an Effective Therapeutic Strategy	23
Evolution of liver function during immune checkpoint inhibitor treatment for hepatocellular carcinoma	23
Gutflix ‘How to Develop Guidelines’ Series	23
Issue Information	22
Diagnostic value of radiological staging and surveillance for T1 colorectal carcinomas: A multicenter cohort study	22
Leishmaniasis in IBD Patients: Challenges of a Rare Opportunistic Disease	22
Faecal incontinence with concurrent disorders of gut‐brain interaction: A worse outcome	22
UEG journal's editorial team	22
Remimazolam Enables Faster Sedation Induction and Recovery Compared With Midazolam in Diagnostic Upper Gastrointestinal Endoscopy: A Multicenter Randomized Controlled Trial	21
Variation in the detection of lymphovascular invasion in T1 colorectal cancer and its impact on treatment: A nationwide Dutch study	21
Sphingosine‐1‐Phosphate Receptor Modulators for the Treatment of Ulcerative Colitis: A Narrative Review Focusing on Safety	21
Editorial: Reducing Post‐Endoscopy Upper Gastrointestinal Cancer—Less Is More?	20
	20
Diastolic dysfunction is associated with cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with liver cirrhosis	20
Environmental risk factors for inflammatory bowel disease	20
	20
Psychological Factors Predict Response to a Low Fermentable Oligo‐, di‐, Monosaccharide and Polyol Dietary Intervention in Irritable Bowel Syndrome: A Prospective Cohort Study	20
Issue Information	20
Plasma Ammonia Levels Predict Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement	20
	19
Response to “Reflections on the Study of Physiological Determinants in Cirrhosis With Ascites”	19

Hepatic Artery Aneurysm Rupture After Double‐Balloon Endoscopy in Biliary Atresia	19
Pancreatic “supercyst”	19
Long‐term outcomes of endoscopic ultrasound‐guided hepaticogastrostomy in patients with malignant biliary obstruction	18
An education‐based telehealth group improves the management and clinical outcomes of patients with inflammatory bowel disease in China (THEIM study)	18
Smoking and colorectal cancer in inflammatory bowel disease: Quantity matters?	18
The Pitfalls of Measuring Burnout Prevalence: μετά the Meta‐Analysis, What Then?	18
Chronic and Idiopathic Pancreatitis—A Personalized Treatment Approach	18
Long‐Term Impact of COVID‐19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities	17
Increased risk of obstructive lung disease in inflammatory bowel disease: A population‐based cohort study	17
Recent advances in the treatment of refractory gastrointestinal angiodysplasia	17
A global survey of health care workers' awareness of non‐alcoholic fatty liver disease: The AwareNASH survey	17
Incidence, characteristics, and predictive factors of post‐colonoscopy colorectal cancer	17
Sex‐related differences in the presentation, management and response to treatment of eosinophilic esophagitis: Cross sectional analysis of EoE CONNECT registry	17
Cost‐effectiveness of pancreas surveillance: The CDKN2A‐p16‐Leiden cohort	17
European Guideline on Pre‐Operative Prevention of Surgical Site Infections Following Digestive Surgery: A Joint Update of the WHO SSI Guideline for Gastrointestinal Surgery by UEG, ESCP, EAES, and SIS	16
Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis: Novel Mechanisms and Prevention by Drugs	16
Intrahepatic splenosis mimicking hepatocellular carcinoma	16
Splenic artery embolisation for splenic injury during colonoscopy: A systematic review	16
	16
UEG Week 2025 Nurse Programme Presentations	16
A Roadmap for Advancing Women's Health in Disorders of the Gut‐Brain Interaction	16
AEG‐AESPANC‐OPGE‐SIED‐SPG Ibero‐Latin American Guidelines on Acute Pancreatitis (iLATAM‐AP)	16
	16
Work productivity and activity impairment in disorders of gut‐brain interaction: Data from the Rome Foundation Global Epidemiology Study	16
Are Education, Socioeconomic Status, and Household Size Dependent Variables Influencing the Developmental Origins of Inflammatory Bowel Disease?	15
Challenges with neuropsychiatric Wilson's disease	15
Letter of Thanks for UEG Week 2025 Reviewers	15
Multi‐Omics Analysis of Ileal Mucosa and Mesentery Before and After Ileocecal Resection in Crohn's Disease	15
Issue Information	15
Are we ready for genetic testing in metabolic dysfunction‐associated steatotic liver disease?	14
Postoperative adjuvant transarterial chemoembolisation improves survival of hepatocellular carcinoma patients with microvascular invasion: A multicenter retrospective cohort	14
Microlithiasis‐Induced Acute Papillitis Triggers Acute Pancreatitis: Where Do We Go From Here?	14
Gastroenterology Training and Career in Women: Challenges and Opportunities	14
Serum Collagen Biomarkers Are Reflective of Tissue Specific Fibroblasts Associated With Ulcerative Colitis Activity and Treatment Response to Ustekinumab	14
Global trends in opioid use for pain management in acute pancreatitis: A multicentre prospective observational study	14
Enteroscopic Balloon Dilation in Small Bowel Stricturing Crohn’s Disease: Long‐Term Outcomes and Risk Factors for Surgery in a Single‐Center Prospective Observational Study	14
Longitudinal Surveillance of Gastric Polyposis in Familial Adenomatous Polyposis: Incidence, Progression, and Endoscopic Outcomes	14
Beyond the numbers: United European Gastroenterology journal's mission to build a community and connect	13
	13
Artificial Intelligence in FIT‐Positive Colonoscopy: Balancing Detection Metrics and Clinical Impact	13
ATG16L1 rs2241880/T300A increases susceptibility to perianal Crohn's disease: An updated meta‐analysis on inflammatory bowel disease risk and clinical outcomes	13
Inflammation remains a dynamic component of portal hypertension in regressive alcohol‐related cirrhosis	13
Clinical relevance of calprotectin in patients with perianal fistulas in Crohn's disease and cryptoglandular fistulas	13
Issue Information	13
Issue Information	13
The Clinical Reality of Endoscopic Sedation: Balancing Pharmacokinetic Efficiency With Diagnostic Excellence	13
Peroral endoscopic myotomy for hypercontractile (Jackhammer) esophagus: A retrospective multicenter series with long‐term follow‐up	13
New endoscopic tools in inflammatory bowel disease	13
Wilson's disease—An early diagnosis to improve outcomes	13
UEG week and UEG journal: A strong scientific liaison	13
Real‐World Molecular Testing in European Early‐Onset Colorectal Cancer	13
European Consensus on Functional Bloating and Abdominal Distension—An ESNM/UEG Recommendations for Clinical Management	13
Evaluating Sex Disparity in Pancreatic Ductal Adenocarcinoma Risk in the UK Biobank Cohort	13
Effectiveness of Gastric Cancer Endoscopic Screening in Intermediate‐Risk Countries—A Systematic Review and Meta‐Analysis	13
Irritable bowel syndrome with food‐related symptoms: Future directions in the clinical management	13
	12
Comparative Study on Burden, Features and Determinants of Disorders of Gut‐Brain Interaction Between Southern Europe and the Rest of Continent: Results From the Rome Foundation Global Epidemiology Stu	12
Endoscopic management of duodenal perforation caused by foreign bodies in adults: A retrospective study	12
Predicting de‐novo portal vein thrombosis after HCV eradication: A long‐term competing risk analysis in the ongoing PITER cohort	12
Gut Microbial Signatures Associated With Clinical Remission in Inflammatory Bowel Disease Treated With Biologics: A Comprehensive Multi‐Cohort Analysis	12
Efficacy of different bowel preparation regimen volumes for colorectal cancer screening and compliance with European Society of Gastrointestinal Endoscopy performance measures	12
Best of UEG Week 2024	12
Correction to European Consensus on Functional Bloating and Abdominal Distension—ESNM/UEG Recommendations for Clinical Management	12
Effective Colorectal Cancer Screening—Adherence is Key	12
No evidence of association between inherited thrombophilia and increased risk of liver fibrosis	11
Rare Case of Mantle Cell Lymphoma With Multiple Rectal Lesions	11
Liver and spleen volumes are associated with prognosis of compensated and decompensated cirrhosis and parallel its natural history	11
Updated German guideline on diagnosis and treatment of squamous cell carcinoma and adenocarcinoma of the esophagus	11
A stalk with no polyp—A muco‐submucosal elongated polyp in the duodenum	11
Coexistent faecal incontinence and constipation: Common but frequently overlooked	11
A Contagious Cause of Rectal Bleeding: Misleading Presentation of Chlamydia trachomatis Infection	11
Association between pancreatic adenocarcinoma risk and concentration of organochlorine pesticides in adipose tissue and urine: A targeted‐screening analysis case‐control study (PESTIPAC)	11
Four‐fold increased mortality rate in patients with Wilson's disease: A population‐based cohort study of 151 patients	11
SARS‐Cov‐2 vaccination is safe in autoimmune pancreatitis patients	11
Overview of a national endoscopy database: The Trans.IT database and its impact on data registration quality	11
Effectiveness of screening endoscopy for esophageal squamous cell carcinoma in Japanese males	11
Systemic therapies in hepatocellular carcinoma: A revolution?	11
European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence‐based recommendations	10
UEG Journal's impact and vision for the future	10
	10

Issue Information	10
	10
Preclinical IBD: One more piece of the puzzle	10
European guidelines on functional bowel disorders with diarrhoea: United European Gastroenterology (UEG) and European Society for neurogastroenterology and motility (ESNM) statements and recommendatio	10
Thrombolysis for haemobilia‐induced biliary obstruction through a cholangiodrainage catheter	10
Abdominal Bloating and Distension: Common Symptoms but Limited Evidence	10
CiThroModel Improves Prediction of Symptomatic Venous Thromboembolism in Hospitalized Patients With Cirrhosis Without Hepatocellular Carcinoma	10
Was Motorized Spiral Enteroscopy Too Risky? A Systematic Review and Meta‐Analysis Including German Registry Data	10
Tofacitinib in chronic pouchitis: A step towards addressing an unmet need	10
‘Call for More Biopsies During Pouchoscopy in Ulcerative Colitis’	10
Remimazolam Preserves Oxygen Reserve and Improves Sedation Safety Compared to Propofol in Endoscopic Retrograde Cholangiopancreatography	10
Risk factors for the occurrence of ampullary tumors: A case‐control study	10
A rare case of squamous cell carcinoma originating from esophageal papilloma	10
Quality of clinical guidelines: It matters as it impacts patient care	9
Asymptomatic Walled‐Off Pancreatic Necrosis: A Prospective Study of Natural Course and Risk Factors for Intervention	9
Symptom profiles compatible with disorders of gut‐brain interaction (DGBI) in organic gastrointestinal diseases: A global population‐based study	9
Bugs and germs in GI‐disease	9
Adiposity as a risk factor for inflammatory bowel disease and the mediating effect of metabolic and inflammatory status: A population‐based cohort study	9
Tofacitinib for the treatment of chronic pouchitis: A pilot study	9
Response to Letter to the Editor	9
Guideline for the assessment and management of gastrointestinal symptoms following colorectal surgery—A UEG/ESCP/EAES/ESPCG/ESPEN/ESNM/ESSO collaboration. Part I—Sequelae to oncological diseases	9
Intra‐abdominal abscesses in CD – When to treat with biologics?	9
Correction to “Small and Stable Pancreatic Cysts Are Reassuring During Surveillance: Results From the PACYFIC Trial”	9
The Learning Curve of Junior Endoscopists in EUS‐Guided Gastroenterostomy With the Wireless Simplified Technique: A Prospective Study	9
UEG Week 2024 Poster Presentations	9
The role of gut microbiome in inflammatory bowel disease diagnosis and prognosis	9
In memoriam: Rolf Hultcrantz (1949–2022)	9
External validation of models to predict hepatocellular carcinoma in Hepatitis C Virus cured F3‐F4 patients	9
Autoimmune pancreatitis—New evidence for clinical management strategies	9
UEG Week 2025 Poster Presentations	9
Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis	9
Clinical features and long‐term outcomes of patients with type 2 autoimmune pancreatitis	9
New insights in the natural course of eosinophilic esophagitis	9
UEG journal: The voice of European Gastroenterology	9
Disorders of gut‐brain interaction: Highly prevalent and burdensome yet under‐taught within medical education	8
Computer‐aided diagnosis in real‐time endoscopy for all stages of gastric carcinogenesis: Development and validation study	8
Ulcerative colitis increases risk of hypertension in a UK biobank cohort study	8
Towards a robust and compact deep learning system for primary detection of early Barrett’s neoplasia: Initial image‐based results of training on a multi‐center retrospectively collected data set	8
Burden of obesity in gastrointestinal and liver diseases	8
Endoscopy‐Related Musculoskeletal Injuries: A Systematic Review and Meta‐Analysis on Prevalence, Risk Factors and Prevention	8
Endoscopists performance in optical diagnosis of colorectal polyps in artificial intelligence studies	8
The Changing Landscape in Patients With Crohn's Disease	8
Darvadstrocel for complex perianal fistulas in Crohn's disease: A systematic review and meta‐analysis	8
5G‐based remote magnetically controlled capsule endoscopy for examination of the stomach and small bowel	8
Intestinal strictures in Crohn's disease: An update from 2023	8
Advancing transmural remission as a treatment target in Crohn's disease: The future of tight‐control strategy?	8
Acute decompensation of cirrhosis versus acute‐on‐chronic liver failure: What are the clinical implications?	8